Objective-Involvement of reactive oxygen species derived from nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase has been documented in the development of hypoxia-induced model of pulmonary arterial hypertension (PAH). Because the PAH-like phenotype was demonstrated in mice deficient in Nox1 gene (Nox1
P ulmonary arterial hypertension (PAH) is characterized by hypertrophy and excessive constriction of small pulmonary arteries. Increased vascular resistance of remodeled arteries elicits right heart failure and causes early death in patients who are susceptible. The prognosis of the disease is poor, with a median survival of 2.8 years if untreated. 1 Multiple pathogenic pathways have been implicated in the development of PAH at the molecular and genetic levels in endothelial cells, vascular smooth muscle cells, and in adventitia. Clinically, an endothelin receptor antagonist, prostacyclin, and activators of the nitric oxide (NO) pathway are used to suppress the accelerated contraction of pulmonary arteries. However, it is increasingly recognized that the pathogenesis of PAH involves an imbalance of proliferation and apoptosis in vascular cells rather than in vascular contraction. 2 Although a complex of lesions is observed in severe PAH, most cases of early phase PAH exhibit isolated medial hypertrophy, characterized by muscularization of small pulmonary arteries that do not normally have a muscular layer. Impaired apoptosis and excessive proliferation of pulmonary arterial smooth muscle cells (PASMCs) are possible mechanisms underlying medial hypertrophy. Among causative factors implicated in the imbalance of PASMC turnover are impaired expression of voltage-gated K + channels, 3, 4 overexpression of serotonin transporter, 5 and de novo expression of the apoptosis inhibitor survivin, 6 although an integral picture of their contribution to PAH pathogenesis still remains elusive.
NOX is the catalytic subunit of nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase, a superoxide-generating enzyme comprising multiple subunits.
7 NOX2 was initially identified as a component of phagocyte NADPH oxidase, defect of which causes a severe genetic immune disorder, chronic granulomatous disease. In recent years, other NOX isoforms have been discovered in nonphagocytic cell lineages constituting gastrointestinal, renocardiovascular, and nervous systems. 7 We previously reported that an inducible isoform of NOX, NOX1, is an exacerbating factor in angiotensin IIinduced hypertension using mice deficient in Nox1 gene. 8 Involvement of reactive oxygen species (ROS) derived from NADPH oxidase has been documented in the development of a hypoxia-induced model of PAH. In mice exposed to hypoxia, vasoconstriction and subsequent vascular remodeling in pulmonary arteries were abolished by Nox2 deficiency. 9 Upregulation of NOX4, another isoform of NOX, was demonstrated not only in mice exposed to hypoxia but also in patients with idiopathic PAH. 10 On the contrary, decreased production of mitochondrial ROS has been documented in the development of PAH. In this model, reduced expression of a voltagegated K + channel, Kv1.5, and increased level of intracellular potassium were demonstrated to perturb PASMC turnover. 3 Accordingly, a unifying mechanism for the onset and development of PAH mediated by ROS remains to be identified.
Because the PAH-like phenotype was depicted in mice deficient in Nox1 gene raised under normoxia, we hypothesized that the lack of NOX1 would lead to spontaneous PAH. Thus, the aim of this study was to clarify how NOX1/NADPH oxidase could contribute to pulmonary pathology underlying the phenotype. Here, we report that ROS derived from NOX1 suppress vascular hypertrophy in pulmonary arteries by maintaining the intracellular potassium levels and the persistent turnover of PASMC.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Histological and Hemodynamic Studies
In an open-chest procedure, we noticed a protrusion of the right ventricle (RV) in Nox1 −/Y reared under a normal atmosphere. Vertical section of the heart stained with hematoxylin-eosin revealed remarkable enlargement of the RV in Nox1
−/Y at 9 weeks ( Figure 1A ). By echocardiographic analyses, the measurements of RV dimensions depicted a significant difference between wild-type (WT) mice (Nox1 +/Y ) and Nox1 −/Y heart ( Figure 1B) . Except for the thickness of the left ventricular (LV) posterior wall in diastole, however, there was no difference between the genotypes in terms of other parameters such as the thickness of interventricular septum in diastole, the systolic, and diastolic LV internal dimensions, and ejection fraction (Materials and Methods in the online-only Data Supplement).
To clarify whether the enlargement of RV in Nox1 −/Y is associated with hypertrophy in RV, the ratio of RV/LV+S mass (wt/wt) was examined. At 5 weeks, there was no difference in the ratio of RV/LV+S between the genotypes. However, at 9 and 18 weeks, a significant increase in the RV/LV+S ratio was observed in Nox1 −/Y compared with that in Nox1 −/Y at 9 weeks, whereas a significant increase was observed at 18 weeks ( Figure 1D ). Decreased RVSP observed at 9 weeks might be attributable to the compensatory dilation of the right ventricular wall in response to an increase in the afterload, whereas hypertrophic adaptation of RV might contribute to elevated RVSP observed at 18 weeks.
Hypertrophy in Pulmonary Arteries of Nox1 −/Y
To determine which organ mainly contributes to the morphological and functional abnormalities demonstrated in RV, the expression levels of NOX1 mRNA in the lung, heart, aorta, and kidney were examined in WT mice (Figure 2A ). Among these organs, the highest level of NOX1 mRNA was demonstrated in the lung, which was mostly unchanged at the ages of 5, 9, and 18 weeks ( Figure 2B ). These results suggest that the abnormality found in RV of Nox1 −/Y may be because of the deficiency of Nox1 in the lung. Therefore, we performed histological analyses of the lung tissue. As shown in Figure 2C, . These <50-μm-diameter vessels were divided into 3 categories as previously described.
11 Namely, they are vessels surrounded by single elastic lamina ( Figure 2D , left, an arrow with a solid line), vessels with partially multiple elastin fiber that are surrounded by internal elastic lamina and in part by external lamina ( Figure 2D , left, an arrow with a dotted line), and vessels with fully multiple elastin fiber that are surrounded fully by internal and external elastic lamina ( Figure 2D , right, an arrowhead). We scored the frequency of these 3 types of vessels. Significant increases in not only fully multiple elastin fiber but also in partially multiple elastin fiber were observed in 9-and 18-week-old Nox1 −/Y . We also observed increased α-smooth muscle actin-positive vessels in Nox1 −/Y at 9 weeks . A, Levels of NOX1 mRNA expressed in various organs. Total RNAs isolated from the lung, heart, aorta, and kidney of Nox1 +/Y at 9 weeks of age were subjected to real-time polymerase chain reaction (PCR , which was made from another embryonic stem cell clone (data not shown). Consequently, a potential role of NOX1/NADPH oxidase in the onset of pulmonary vascular remodeling was suggested.
An excessive increase in proliferative and apoptosis-resistant endothelial cells has been documented among the causative factors involved in the pathogenesis of PAH. 12 However, when immunostained with an anti-cluster of differentiation 31 antibody, there was no difference in the intimal thickness of pulmonary vessels between the 2 genotypes ( Figure 2F ).
Expression of Various Factors Implicated in the Development PAH
In hypoxia-induced pulmonary hypertension, involvement of NOX2 and NOX4 has been reported. 9 ,10 Therefore, we examined whether any compensatory change takes place in the expression of NOX2 and NOX4 in Nox1 −/Y . Pulmonary vessels were isolated by laser capture microdissection, and the levels of mRNA were determined by real-time polymerase chain reaction. The levels of NOX2 and NOX4 were unchanged in
Nox1
−/Y vessels, indicating no compensatory overexpression of other NOX isoforms ( Figure 2G) . Furthermore, the levels of endothelin-1 and hypoxia-inducible factors, HIF-1α and -2α, also remained unchanged in Nox1 −/Y pulmonary vessels. Further investigation on the expression of eNOS mRNA and the production of NO in the lung indicated no difference between the genotypes at 5, 9, and 18 weeks ( Figure I in the online-only Data Supplement). These findings indicated that the lack of Nox1 did not affect the expression of other NOX isoforms or pathogenic pathways implicated in PAH.
Increased Number of PASMCs Isolated From Nox1
−/Y in Culture . Similar to the findings in microdissected vessels, there was no compensatory change in mRNA levels of NOX2 and NOX4 in PASMCs isolated from Nox1 −/Y ( Figure 3A ). As shown in Figure 3B , a trypan blue exclusion assay revealed a small but significant increase in the number of viable cells in Nox1 24 hours. When cell proliferation was evaluated by incorporation of bromodeoxyuridine, however, it was slightly decreased in PASMCs isolated from Nox1 −/Y ( Figure 3C ). In accordance with these findings, an increase in cells in the G1 phase with a decreased population in the S/G2 phase was demonstrated in Nox1 −/Y PASMCs ( Figure 3D ). Concomitantly, the proportion of cells in sub-G1 was significantly attenuated in PASMCs of Nox1 −/Y . These findings suggest a dual role of NOX1-derived ROS in facilitating the proliferation and apoptosis of PASMCs, which is similar to the role of hydrogen peroxide reported in cancer cells. 13 An overall increase in viable cells demonstrated in Nox1 −/Y PASMCs implies that reduced cellular apoptosis rather than suppressed proliferation plays a dominant role in the development of pulmonary vascular hypertrophy in Nox1-deficient mice. In fact, terminal deoxynucleotidyl transferase dUTP nick end labeling staining clearly demonstrated a significant decrease in terminal deoxynucleotidyl transferase dUTP nick end labelingpositive cells in PASMCs obtained from Nox1 −/Y ( Figure 3E ). To further clarify the mechanism of cellular apoptosis in PASMCs, we examined the effect of z-VAD fmk, a pan-caspase inhibitor. Interestingly, the proportion of cells in sub-G1 phase was unaffected by z-VAD fmk ( Figure 3F ). Therefore, it was assumed that NOX1-mediated apoptosis in PASMCs uses the caspase-independent pathway(s). Apoptosis-inducing factor (AIF) is one of the factors that involved in initiating a caspase-independent apoptosis.
14 AIF translocates to the nucleus, where it triggers chromatin condensation and DNA fragmentation. When we examined nuclear AIF levels by Western blot, a decreased AIF level was demonstrated in PASMCs of Nox1 −/Y ( Figure 3G ). These results suggest that NOX1-derived ROS accelerate translocation of AIF to the nucleus and induce caspase-independent apoptosis.
Genetic Rescue Studies
To verify further the role of NOX1 in the development of PAH, we used F1 hybrid mice derived from Nox1 −/Y crossed with Nox1-transgenic mice (TG) expressing rat NOX1 mRNA. Two lines of TG, 12 L and 39l, showed 7 and 9.0×10 
Gene Expression Profiling in PASMCs
To elucidate the molecular mechanisms underlying NOX1-mediated alteration in PASMC turnover, we first examined the expression of survivin and serotonin transporter. The involvement of survivin and serotonin transporter was documented in the development of PAH by inducing hyperplasia and apoptosis of PASMCs. 5, 6 However, no significant change was observed in the expression of survivin and serotonin transporter (data not shown). Next, we extracted 4 genes, Nav3, Birc1e, Irak2, and E2F2, which are related to apoptosis and cell cycle by gene ontology term analysis after the global analysis of mRNA expression profile by oligonucleotide array. However, when confirmed by real-time polymerase chain reaction, there was no significant difference in mRNA expression between the genotypes (Table III in the online-only Data Supplement). As for the genes implicated in the pathogenesis of PAH, including those related to bone morphogenetic protein, hypoxia-inducible factors, endothelins, serotonin, prostaglandin, nitric oxide, 15 and p53, no change was detected in PASMCs derived from Nox1 −/Y (Table IV in the online-only Data Supplement). These results indicated that expression of genes previously implicated in PAH or cellular apoptosis was unaffected by Nox1 deficiency.
Study on Protein Kinases
ROS have been shown to regulate protein functions through multiple mechanisms, including regulation of protein expression, post-translational modifications, and alteration of protein stability. Post-translational modifications such as oxidation and phosphorylation of proteins either activate or inactivate their functions. Recently, ROS derived from NADPH oxidase were implicated in apoptosis by direct activation of proapoptotic kinases. 16 Therefore, we examined the phosphorylation of mitogen-activated protein kinases, extracellular signal-regulated kinase 1/2, p38, and c-Jun N-terminal kinase. No significant difference in these kinases was observed in PASMCs obtained from Nox1 +/Y and Nox1 −/Y ( Figure II in the online-only Data Supplement). Phosphorylation of Akt is known to block the apoptotic pathway by regulating proapoptotic proteins such as Bad and caspase-9. 17 Recently, we reported that ROS derived from NOX1 positively regulate the Akt/forkhead box protein O4/p27 kip1 signaling pathway to promote proliferation of hepatic stellate cells. 18 However, as opposed to these findings, no difference in phosphorylated/total Akt was observed between the 2 genotypes (data not shown). Accordingly, the phosphorylation state of mitogen-activated protein kinases or Akt was not associated with reduced apoptosis observed in Nox1 −/Y PASMCs.
Reduced Level of Kv1.5 Protein in Nox1 −/Y PASMCs
Previously, involvement of decreased mitochondrial ROS production and ensuing reduction in Kv1.5, a voltage-gated K + channel, was reported in the development of PAH. 3 Decreased ROS production from mitochondria suppressed the expression of Kv1.5 protein and increased intracellular potassium levels, leading to abnormal PASMC turnover. Therefore, we examined mitochondrial ROS production using MitoSOX Red staining. As shown in Figure III To verify further the effect of Nox1 deficiency on Kv1.5 expression, genetically rescued mice were investigated. As shown in Figure 5C , reduced levels of Kv1.5 protein in Nox1 −/Y PASMC were significantly restored in cells obtained from Nox1
−/Y crossed with TG. Then, we examined whether the upregulation of NOX1 mRNA could elevate the level of Kv1.5 protein in PASMCs. Previously, increased expression of NOX1 mRNA by serum starvation was reported in FaO rat hepatoma cells. 19 In the present study, we also found that the level of NOX1 mRNA was significantly elevated in PASMCs under serum starvation ( Figure 5D) . Concomitantly, the level of Kv1.5 protein was significantly increased, whereas it remained unaltered in PASMCs isolated from Nox1 −/Y ( Figure 5E ). In line with these findings, treatment with the antioxidant N-acetylcysteine (NAC) significantly attenuated the level of Kv1.5 protein in PASMCs obtained from Nox1 +/Y , but not in those from Nox1 −/Y ( Figure 5F ). These findings clearly indicated that the expression of Kv1.5 protein was regulated in a NOX1-dependent manner.
Increased Intracellular Potassium in Nox1
−/Y PASMCs Because Kv1.5 regulates the membrane potential and vascular tone, loss of Kv1.5 elicits sustained depolarization and elevates intracellular potassium, thereby inhibiting cellular apoptosis. 20 Therefore, we measured intracellular potassium level using PBFI-AM, an indicator of intracellular potassium. To confirm the specificity of PBFI-AM, changes of emission ratio in the presence of 1 μmol/L valinomycin, a potassium ionophore, or 180 mmol/L of KCl was examined. In a representative experiment, the emission ratio of 1.084 declined to 0.884 at 5 minutes after the application of valinomycin to Nox1 +/Y PASMCs, whereas the ratio increased to 1.504 after high KCl exposure. As demonstrated in Figure 6A , high signals (red and yellow) were 
Discussion
In this study, we demonstrated for the first time the role of NOX1 in pulmonary vascular remodeling using genetically modified mice. ROS derived from NOX1/NADPH oxidase were shown to play a critical role in the physiological turnover of PASMCs by regulating Kv1.5 expression and intracellular potassium levels. Reduced NOX1/NADPH oxidase activity may be a novel causative factor in the pathogenesis of PAH.
In contrast to our present findings, previous reports indicated that NADPH oxidase is a factor that exacerbates the development of PAH. Deficiency of the phagocytic form of NADPH oxidase, Nox2, reduced chronic hypoxia-enhanced vasoconstrictor activity seen in pulmonary arteries of WT mice. 9 On the contrary, upregulation of NOX4 was observed in experimental model mice under hypoxia and in pulmonary arteries of patients with idiopathic PAH. Knockdown of NOX4 by siRNA suppressed proliferation of human donor PASMCs. 10 Although these studies demonstrated that ROS derived from NOX2 and NOX4 exacerbate hypoxia-induced PAH, little is known on the role of ROS in the onset of spontaneous PAH. We demonstrated that deficiency of Nox1 elicits hypertrophy in RV and pulmonary arteries, which are typical findings in patients with PAH. As opposed to the role for other NOX isoforms, inactivation of NOX1/NADPH oxidase may thus be one of the causative factors in idiopathic PAH.
Dysfunction of endothelial cells has been implicated in the development of PAH. Endothelial proliferative plexiform lesions are typical morphological features observed in patients with PAH. In the present study, immunostaining of cluster of differentiation 31 failed to detect any difference in the intimal thickness between the 2 genotypes. The level of endothelin-1 and bioactivity of NO derived from eNOS 15 are known pathogenic factors involved in endothelial dysfunction. However, there was no significant alteration in the expression of endothelin-1 in the lung as well as in pulmonary vessels in Nox1 −/Y . Because the crosstalk between NO and ROS derived from NOX1 was indicated in the pressor response to Ang II, 8 we examined the expression of eNOS mRNA and endogenous production of NO in the lung. The balance between proliferation and apoptosis of PASMC is known to be vital in maintaining the structural and functional integrity of the pulmonary vasculature. 21 In human neutrophils, it was reported that inhibition of K + efflux by high extracellular KCl attenuated translocation of caspase-independent proapoptotic factors, AIF and endonuclease G, from mitochondria to nuclei. 22 In this study, increased intracellular K + and decreased nuclear AIF were demonstrated in PASMCs form Nox1 −/Y . Accordingly, the K + channel-AIF pathway may be affected by Nox1 deficiency and decelerate cellular apoptosis in PASMCs.
In the present study, no alteration was observed in the expression level of Kv1.5 mRNA, whereas a significant decrease in Kv1.5 protein was demonstrated in Nox1 −/Y . Recently, depressed production of ROS from mitochondria was reported to elicit normoxic activation of HIF-1α, which inhibits expression of Kv1.5 in PASMCs. 3 It was assumed that activation of HIF-1α, which binds to a putative hypoxic response element in the 5′-untranslated region of the Kv1.5 gene, attenuates the expression of Kv1.5.
3 When mitochondrial ROS production was examined using MitoSOX Red staining, fluorescence intensity in PASMCs obtained from Nox1 −/Y was equivalent to that in PASMCs obtained from Nox1
. The mechanism involved in reduced Kv1.5 protein by Nox1 deficiency may thus be distinct from mitochondrion-mediated activation of HIF-1α. It should be noted that not only upregulation of Nox1 mRNA but also suppression of intracellular oxidative stress by an antioxidant affected the level of Kv1.5 protein in PASMCs. Nevertheless, treatment with hydrogen peroxide did not alter the expression of Kv1.5 protein in PASMCs obtained from either genotype (data not shown). Accordingly, ROS derived from intracellular and extracellular sources seemed to have different effects on the expression of Kv1.5 protein in PASMCs.
Many proteins are degraded through the ubiquitin-proteasome system, 23 and the ubiquitin-activating enzyme E1 as well as proteasomes are inactivated by ROS. 24 On the contrary, increased oxidative modification of Kv1.5 was recently reported to elicit proteasomal degradation. 25 When the effects of proteasome inhibitors on the expression of Kv1.5 protein in PASMC were examined, no significant alteration in the level of Kv1.5 protein was observed. ROS also regulate the expression of miRNAs, noncoding RNAs that act post-transcriptionally to bind complementary sequences on target mRNAs, generally resulting in translational repression. Notably, miRNAs are sensitive to ROS and participate in hydrogen peroxide-mediated gene regulation and cellular injury in vascular smooth muscle cells. 26 Therefore, we performed global analysis of miRNA expression using oligonucleotide array and extracted 4 candidate miRNAs with complementary sequences to Kv1.5 mRNA, mmu-let-7f, mmu-miR-23a, mmu-miR-30e, and mmu-miR-18a. However, no significant difference in these miRNA levels was observed between the genotypes by realtime polymerase chain reaction ( Figure V in the online-only Data Supplement). Because there are miRNAs that have not been identified in mice, a possibility remains that a hitherto unidentified miRNA that represses the translation of Kv1.5 is regulated by ROS derived from NOX1.
During the course of this study, it was reported that oxidative modification of Kv1.5 by NOX4-derived ROS leads to inhibition of Kv channel current in rat PASMCs without affecting the level of Kv1.5 protein. 27 Furthermore, recent work in stable cell lines revealed that surface expression of Kv1.5 was downregulated by redox-sensitive sulfenic acid modification. 25 Therefore, we examined oxidative modification of Kv1.5 in PASMCs by labeling with maleimidepolyethylene glycol followed by immunoblotting with an anti-Kv1.5 antibody. However, we could not identify any specific band corresponding to the oxidized Kv1.5 form(s) against the background (data not shown). On the contrary, ROS are known to directly activate cysteine-rich Kv channels. 28 They are inhibited when reduced and activated when oxidized. This admits the possibility that ROS derived from NOX1 regulate intracellular potassium level not only by maintaining the expression of Kv1.5 protein but also by directly enhancing Kv channel current.
In conclusion, inactivation of NOX1/NADPH oxidase may trigger an imbalance in PASMC turnover and elicit medial hypertrophy in pulmonary arteries. The present study provided insight into the novel function of NOX1-derived ROS in maintaining the homeostasis of pulmonary vessels.
In mice deficient in NOX1, a catalytic subunit of nonphagocytic NADPH oxidase, a phenotype resembling that seen in pulmonary arterial hypertension (PAH) was depicted at 9 to 18 weeks. When the pathology underlying enlargement and hypertrophy of the RV, accompanied by hypertrophy of pulmonary vessels, was investigated, a novel role for NOX1/NADPH oxidase in pulmonary vascular remodeling was demonstrated. By maintaining the levels of a voltage-dependent K + channel, Kv1.5, and intracellular potassium, NOX1 modulates the persistent turnover of pulmonary artery smooth muscle cells. Although previous studies demonstrated that reactive oxygen species derived from other NOX isoforms, NOX2 and NOX4, exacerbate hypoxia-induced PAH, little is known on the role of NOX in maintaining the homeostasis of pulmonary vessels. This is the first report suggesting the involvement of NOX1/NADPH oxidase, acting upstream of Kv1. mRNA, mmu-let-7f, mmu-miR-23a, mmu-miR-30e, and mmu-miR-18a were extracted.
Levels of miRNA were determined by real-time PCR. n=6 per group. The data are means ± S.E.M. 
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E2f2
E2F transcription factor 2 100.0±20.6 109.5±20.0
Four genes, Nav3, Birc1e, Irak2, and E2F2, were extracted by oligonucleotide array analysis. Levels of mRNA were determined by real-time PCR. n=6 per group. Data are means ± S.E.M., expressed as percent of Nox1(+/Y). 
Supplementary
MATERIALS AND METHODS
Animals
Male Nox1-deficient mice (Nox1 -/Y ) previously generated in our laboratory 1 
and
Nox1 transgenic mice (Nox1-TG) of a C57BL6 background were used with respective wild-type littermates. All animals were maintained on a 12 hours light/dark cycle and fed ad libitum. The study was carried out with the approval of the Committee for Animal Research at Kyoto Prefectural University of Medicine.
Production of Nox1 transgenic mice
The transgene contains a cytomegalovirus-immediate early enhancer and chicken β-actin promoter driving the rat-Nox1 coding regions. It was microinjected into the male pro-nuclei of zygote obtained from super-ovulated BDF-1 female mice crossed with male BDF-1. The zygotes were implanted in pseudopregnant female mice and allowed to develop. The presence of transgene was detected by Southern blot analysis and polymerase chain reaction with the primers 5' gaagattcttggctaaatcccatc3' and 5'ggtgagtgctgttgttcaaatg3' using DNA extracted from mouse tail. Transgenic mice were backcrossed to C57BL/6 for more than 8 generations.
Immunohistochemical and morphometric analyses
Tissues isolated from mice under pentobarbital anesthesia (50 mg/kg, i.p.) were fixed in 4% paraformaldehyde/ phosphate-buffered saline (PBS) overnight, washed three times with PBS, and embedded in polyester wax or paraffin. The 5-µm sections were stained with anti-CD31 (PharMingen, San Diego, CA) and anti-α smooth muscle actin (DAKO, Glostrup, Denmark) antibodies overnight at 4°C as previously described 2 . After washing with PBS containing 0.1% Tween 20, the sections were further incubated with a horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (IgG) antibody (Biosource, San Diego, CA). Counterstaining was carried out using hematoxylin.
Victoria blue-van Gieson staining was performed using Victoria blue reagent and a van Gieson reagent kit (Muto, Tokyo, Japan). To assess the frequency of microvessels surrounded by elastin fibers, the number of vessels less than 50 µm in diameter was counted by microscopy. More than 100 vessels per mouse were evaluated and categorized.
Hemodynamic measurements
With body temperature controlled at 37°C using small-animal warmers, mice 
Real-time PCR
Expression levels of mRNAs were evaluated by real-time PCR as previously described with a modification 3 . Total RNA was isolated by the acid guanidinium thiocyanate/phenol/chloroform method. Real-time PCR was performed using the 
Cell culture
Heart and lung tissues were removed from the thorax and placed in MEM Following incubation on a rotator plate for 90 minutes at 37°C, the resulting solution was passed through a 100 µm cell strainer and centrifuged. The pelleted smooth muscle cells (PASMC) were resuspended in DMEM/F-12 medium containing 10% FBS, and pipetted into a 48-well plate. The 4 th passage of these cells was used for the study.
Detection of cell proliferation
Cell proliferation was measured by BrdU (5-bromo-2′-deoxyuridine) incorporation assay using a CycLex Cellular BrdU ELISA Kit (CycLex, Nagano, Japan). Briefly, PASMC (10 4 cells/well) were grown in 96-well plates for 24
hours. BrdU was applied to the medium and incubated for another 2 hours.
Denatured cells were exposed to anti-BrdU monoclonal antibody followed by 
Statistical analyses
Values are expressed as means ± S.E.M. Statistical analyses were performed with one-way ANOVA. For multiple datasets, a post hoc multiple comparison
